Home > Journals > Minerva Pediatrica > Past Issues > Minerva Pediatrica 2004 April;56(2) > Minerva Pediatrica 2004 April;56(2):161-6

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA PEDIATRICA

A Journal on Pediatrics, Neonatology, Adolescent Medicine,
Child and Adolescent Psychiatry


Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,532


eTOC

 

REVIEWS  


Minerva Pediatrica 2004 April;56(2):161-6

language: English

Pharmacological strategies in the idiopatic pulmonary fibrosis of children

Rigante D., Stabile A.


PDF  


Idiopathic pulmonary fibrosis is characterized by radiographically evident interstitial infiltrates and progressive dyspnea with rapid decline of overall lung functions. The clinical course of this disease is highly variable; however, its prognosis remains poor without adequate and prompt therapeutical support. Due to the fact that barely a quarter of patients responds to steroids alone, cytostatics are often prescribed simultaneously with low dose corticosteroids in the pediatric age too. Cytokine or anti-cytokine therapy and the role of new antifibrotic drugs are still at the experimental stage of definition and will be discussed in the following review.

top of page

Publication History

Cite this article as

Corresponding author e-mail